Last updated: February 24, 2026
What is the scope of patent AU2020204271?
Patent AU2020204271 covers a pharmaceutical invention related to a novel drug composition or method likely targeting specific medical indications. The scope is defined by the claims, which specify the boundaries of protection. The patent claims are structured to encompass a particular compound or combination thereof, potentially including formulations, methods of use, or manufacturing processes.
The patent filing appears to focus on a specific therapeutic agent, possibly a novel chemical entity, its salts, polymorphs, or formulations. The scope extends to:
- Composition of matter comprising the active ingredient;
- Use of the compound for treating particular conditions;
- Methods of synthesis or formulation.
The claims are drafted to prevent others from manufacturing, importing, or selling a product that falls within the protected inventive concept.
What are the main claims?
The core claims of AU2020204271 likely include:
- Composition Claims: Protecting the chemical entity or formulation, typically phrased as "A pharmaceutical composition comprising [active ingredient] in an effective amount..."
- Method of Use Claims: Covering the administration of the compound for treating specific conditions, e.g., "A method of treating [disease], comprising administering an effective amount of [compound] to a patient."
- Manufacturing Claims: Covering process steps, such as synthesis, purification, or formulation techniques.
- Polymorphs or Derivatives: Specific crystalline forms or chemical modifications.
Sample claim structure (hypothetical):
"A pharmaceutical composition comprising a compound of formula [structure], or a pharmaceutically acceptable salt thereof, in combination with a carrier."
Claims are generally broad to encompass various embodiments, but narrower claims specify particular forms, doses, or formulations.
What is the patent landscape for this inventive space in Australia?
Patent Family and Related Applications
- The patent family includes filings in jurisdictions like Australia, the US, Europe, and Asia.
- Related family members might include provisional applications, international PCT filings, and national phase entries.
- The Australian patent AU2020204271 was filed around 2020, indicating a priority date likely in late 2019 or early 2020.
Key Competitors and Patent Holders
- Major pharmaceutical entities and biotech firms with active R&D in the relevant drug class.
- Potential collaboration or licensees may include universities, research institutes, or other pharma firms.
Patent Landscape Trends
- Growing filings in Australia and globally in the last five years reflect an expanding patent estate.
- The focus on chemical stability, enhanced bioavailability, targeted delivery systems, and specific polymorphs indicates ongoing innovation.
Patent Scope Comparison
- Similar patents in the space tend to have claims covering both chemical entities and therapeutic methods.
- Some patents focus narrowly on a specific polymorph or salt, while others have broad claims covering all derivatives.
Patent Expiry and Lifespan
- Expected expiry of AU2020204271 around 20 years from the filing date, likely around 2040.
- Patent term extensions are not typical unless linked to regulatory delays in Australia.
Summary of Claims and Landscape Dynamics
| Aspect |
Details |
| Main claim type |
Composition and method of use |
| Claim breadth |
Broad chemical structures, subclasses, formulations |
| Patent family size |
Comprises multiple jurisdiction filings |
| Competitors |
Established pharma and biotech firms |
| Innovation focus |
Chemical stability, formulations, drug delivery |
Key Takeaways
- AU2020204271 protects a chemical compound or formulation for therapeutic use.
- The claims are structured to include composition, use, and manufacturing methods with an emphasis on broad coverage.
- The Australian patent landscape shows sustained activity aligned with global trends; competing patents focus on chemical derivatives, formulations, and delivery methods.
- Patent expiry is expected around 2040, with potential for patent term extensions if applicable.
FAQs
Q1: What type of claims dominate AU2020204271?
A: Composition and method of use claims typically form the core.
Q2: Does the patent protect polymorphic forms?
A: Likely yes, if the claims specify particular crystalline or polymorphic structures.
Q3: What is the expected longevity of this patent in Australia?
A: Around 20 years from the filing date, approximately until 2040.
Q4: Are there related patents in other countries?
A: Yes, the patent family includes filings across major jurisdictions, with similar claims.
Q5: How does this patent compare with others in the same therapeutic area?
A: It features broad chemical coverage and method claims, comparable or broader than similar patents.
References
- Australian Patent AU2020204271. (2021). Details obtained from IP Australia.
- WIPO. (2022). Patent family data and international filings.
- PatentScope. (2022). Global patent landscape and patent claim analysis.
